Philips behaalt in het derde kwartaal een vergelijkbare omzetgroei van 2% naar EUR 5,8 miljard en een verbeterd operationeel resultaat van EUR 570 miljoen

oktober 26, 2015

Hoogtepunten derde kwartaal 
  • De vergelijkbare omzet steeg met 2%, met name dankzij Noord-Amerika, de Aziatisch-Pacifische regio en Centraal & Oost-Europa
  • Gecorrigeerd voor valuta-effecten nam de orderontvangst toe met 2%, voornamelijk door een groei van 6% in Noord-Amerika
  • De EBITA, exclusief herstructurerings- en overnamegerelateerde lasten en overige posten, bedroeg EUR 570 miljoen, ofwel 9,8% van de omzet, vergeleken met 9,1% van de omzet in het derde kwartaal van 2014
  • De EBITA kwam uit op EUR 429 miljoen, ofwel 7,4% van de omzet, tegenover een verlies van EUR 62 miljoen in het derde kwartaal van 2014
  • Het nettoresultaat bedroeg EUR 324 miljoen, vergeleken met een nettoverlies van EUR 103 miljoen in het derde kwartaal van 2014
  • Een vrije kasstroom van EUR 58 miljoen, tegenover EUR 155 miljoen in het derde kwartaal van 2014
  • Philips geeft update over verkoop Lumileds
  • Afsplitsingsproces van Philips Lighting verloopt volgens schema

 
Frans van Houten, CEO: 
“Philips heeft in het derde kwartaal van 2015 een stijging van de resultaten gerealiseerd. Hieruit blijkt dat onze operationele resultaten blijven verbeteren, ondanks de verslechterende macro-economische omstandigheden in een aantal markten, vooral in China.
 
De vergelijkbare omzet en orderontvangst van Healthcare zijn gestegen, met name dankzij Noord-Amerika. Ook de operationele resultaten verbeterden ten opzichte de overeenkomstige periode van vorig jaar, ondanks de invloed van China en negatieve wisselkoerseffecten. Consumer Lifestyle heeft opnieuw sterk gepresteerd, met een significante verbetering van de productmix dankzij een krachtige groei van Health & Wellness en Personal Care. Lighting blijft haar resultaten verbeteren ten opzichte de overeenkomstige periode van vorig jaar. Dit is met name het gevolg van de sterke groei van onze LED-activiteiten, terwijl we de achteruitgang van conventionele verlichtingsproducten actief blijven managen.
 
Voor heel 2015 verwachten we een bescheiden groei van de vergelijkbare omzet en een verbetering van onze operationele resultaten.”
 
 
Update over verkoop meerderheidsbelang in Lumileds aan GO Scale Capital 

Bij het verkrijgen van wettelijke goedkeuring voor de verkoop van een belang van 80,1% in Lumileds aan een consortium onder leiding van GO Scale Capital, heeft de Amerikaanse toezichthouder Committee on Foreign Investment in the United States (CFIUS) bepaalde onvoorziene bezwaren geuit. Philips en GO Scale Capital blijven in gesprek met CFIUS en zullen alle redelijke stappen nemen om de bezwaren weg te nemen, maar tot dat moment is de afronding van de transactie onzeker.

 

 

Klik hier voor het volledige Engelstalige persbericht

 


Quarterly Report

Q3 2015 - Quarterly Report
 

 

Presentation

Q3 2015 - Quarterly Results Presentation
 

Conference call and audio webcast

 

A conference call with Frans van Houten, CEO, and Abhijit Bhattacharya, CFO, to discuss the results, will start at 10:00AM CET. A live audio webcast of the conference call will be available through the link below.

 

Q3 2015 conference call audio webcast


More information about Frans van Houten and Abhijit Bhattacharya

Click here for Mr. van Houten's CV and images

Click here for Mr. Bhattacharya's CV and images


Philips and Catharina Hospital sign technology agreement for new and largest cardiovascular center in the Netherlands

 Leveraging its strength in interventional cardiology, Philips signed a multi-year technology agreement with the Catharina Hospital, the largest cardiovascular center in the Netherlands, comprising the equipment, software, upgrades and maintenance services for five interventional rooms and two hybrid operating rooms.

Philips strengthens collaboration with Amazon Web Services to expand digital health solutions in the cloud

 Philips expanded the capabilities of its HealthSuite Digital Platform, a secure cloud infrastructure for health data and devices. The company strengthened the collaboration with Amazon Web Services to broaden the platform’s connectivity capabilities. In collaboration with Radboud University Medical Center and Salesforce, Philips developed a prototype app that runs on the platform to enhance diabetes care.

Philips announced personal health systems at IFA

Philips expanded the capabilities of its HealthSuite Digital Platform, a secure cloud infrastructure for health data and devices. The company strengthened the collaboration with Amazon Web Services to broaden the platform’s connectivity capabilities. In collaboration with Radboud University Medical Center and Salesforce, Philips developed a prototype app that runs on the platform to enhance diabetes care.   

Philips Oral Healthcare delivered double-digit growth

 Further expanding category leadership and driving market share, Philips Oral Healthcare delivered double-digit growth, with strong performance globally. Innovations supporting healthier teeth and gums, like the Philips Sonicare DiamondClean Amethyst and Philips Sonicare AirFloss Pro, coupled with digital marketing and professional.

Philips Hue Lightstrip Plus: light bright enough to paint a whole room

 Philips expanded its leadership in the connected lighting business with the introduction of Philips Hue Lightstrip Plus, the Philips Hue wireless dimming kit and Philips Hue Bridge 2.0. The new bridge enables Philips Hue to interact with other Apple HomeKit devices and become voice-controlled.   

Philips introduced ColorSpark

 Further expanding its technology leadership in LED, Philips introduced ColorSpark, an innovative LEDbased technology that increases the brightness of projectors by a factor of three compared to existing LED-based solutions. It will be brought to market by major brands in the first quarter of 2016.

Leading global health institutions digitize pathology workflows with Philips to enhance disease diagnoses

 Philips’ Digital Pathology Solutions continues to gain traction in the market. In Europe and Asia Pacific, leading health institutions such as Germany’s largest telemedicine platform and Singapore General Hospital digitize their pathology workflows with Philips’ IntelliSite Pathology Solutions to enhance disease diagnoses, while in the US, Genomic Health will utilize Philips’ solutions in their operations to optimize their genomic testing process.

Philips became Leader in the Industrial Conglomerates category

 In the 2015 Dow Jones Sustainability Index, Philips became Leader in the Industrial Conglomerates category, with top scores for its Best in Class performance on Climate Strategy, Product Stewardship and Supply Chain Management.

For further information, please contact:

Steve Klink
Philips Group Communications
Tel: +31 6 10888824
E-mail: steve.klink@philips.com

Joost Akkermans
Philips Group Communications
Tel.: +31 6 3175 8996
E-mail: joost.akkermans@philips.com

.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 106,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

 

.

Forward-looking statements

This document and the related oral presentation, including responses to questions following the presentation, contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.


These factors include but are not limited to domestic and global economic and business conditions, developments within the euro zone, the successful implementation of Philips’ strategy and the ability to realize the benefits of this strategy, the ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, the ability to identify and complete successful acquisitions, including Volcano, and to integrate those acquisitions into the business, the ability to successfully exit certain businesses or restructure the operations, the rate of technological changes, political, economic and other developments in countries where Philips operates, industry consolidation and competition. As a result, Philips’ actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements. For a discussion of factors that could cause future results to differ from such forward-looking statements, see the Risk management chapter included in the Annual Report 2014 and the “Risk and uncertainties” section in the semi-annual financial report for the six months ended June 30, 2015.

Third-party market share data


Statements regarding market share, including those regarding Philips’ competitive position, contained in this document are based on outside sources such as research institutes, industry and dealer panels in combination with management estimates. Where information is not yet available to Philips, those statements may also be based on estimates and projections prepared by outside sources or management. Rankings are based on sales unless otherwise stated.

Use of non-GAAP information


In presenting and discussing the Philips Group financial position, operating results and cash flows, management uses certain non-GAAP financial measures. These non-GAAP financial measures should not be viewed in isolation as alternatives to the equivalent IFRS measures and should be used in conjunction with the most directly comparable IFRS measures. Non-GAAP financial measures do not have standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other issuers. A reconciliation of these non-GAAP measures to the most directly comparable IFRS measures is contained in this document. Further information on non-GAAP measures can be found in the Annual Report 2014.

Use of fair-value measurements


In presenting the Philips Group financial position, fair values are used for the measurement of various items in accordance with the applicable accounting standards. These fair values are based on market prices, where available, and are obtained from sources that are deemed to be reliable. Readers are cautioned that these values are subject to changes over time and are only valid at the balance sheet date. When quoted prices or observable market data are not readily available, fair values are estimated using appropriate valuation models and unobservable inputs. Such fair value estimates require management to make significant assumptions with respect to future developments, which are inherently uncertain and may therefore deviate from actual developments. Critical assumptions used are disclosed in the Annual Report 2014. Independent valuations may have been obtained to support management’s determination of fair values.

Presentation


All amounts are in millions of euros unless otherwise stated. All reported data is unaudited. Financial reporting is in accordance with the accounting policies as stated in the Annual Report 2014, unless otherwise stated. The presentation of certain prior-year information has been reclassified to conform to the current-year presentation.


In 2014, we announced plans to establish two standalone companies focused on the HealthTech and Lighting opportunities. The proposed separation of the Lighting business impacts all businesses and markets as well as all supporting functions and all assets and liabilities of the Group. Philips expects to complete the separation of the Lighting business in the first half of 2016. We expect to continue reporting in the existing structure until the changes in the way we allocate resources and analyze performance in the new structure have been completed.

.